Beutel, Goodman & Co Ltd.
- SEC CIK
- 0001361974
- Latest filing
- Aug 12, 2026
BIIB holding history
Biogen Inc. in every 13F filed by Beutel, Goodman & Co Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BIIB overviewAll 13F holders of BIIBFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −10−100.0% | Sold out | Holders |
| Q1 2025 | 10 | $1.00K | <0.1% | −1,746,467−100.0% | Reduced | Holders |
| Q4 2024 | 1,746,477 | $267.1M | 1.5% | +2,323+0.1% | Added | Holders |
| Q3 2024 | 1,744,154 | $338.1M | 1.7% | −3,290−0.2% | Reduced | Holders |
| Q2 2024 | 1,747,444 | $405.1M | 2.2% | +181,659+11.6% | Added | Holders |
| Q1 2024 | 1,565,785 | $337.6M | 1.7% | +570,329+57.3% | Added | Holders |
| Q4 2023 | 995,456 | $257.6M | 1.4% | −3,820−0.4% | Reduced | Holders |
| Q3 2023 | 999,276 | $256.8M | 1.5% | −700.0% | Reduced | Holders |
| Q2 2023 | 999,346 | $284.7M | 1.6% | +21,620+2.2% | Added | Holders |
| Q1 2023 | 977,726 | $271.8M | 1.6% | +22,830+2.4% | Added | Holders |
| Q4 2022 | 954,896 | $264.4M | 1.6% | −3,085−0.3% | Reduced | Holders |
| Q3 2022 | 957,981 | $255.8M | 1.7% | −8,205−0.8% | Reduced | Holders |
| Q2 2022 | 966,186 | $197.0M | 1.2% | +26,025+2.8% | Added | Holders |
| Q1 2022 | 940,161 | $198.0M | 1.1% | +26,625+2.9% | Added | Holders |
| Q4 2021 | 913,536 | $219.2M | 1.3% | +363,520+66.1% | Added | Holders |
| Q3 2021 | 550,016 | $155.6M | 1.0% | +415,883+310.1% | Added | Holders |
| Q2 2021 | 134,133 | $46.4M | 0.3% | −38,399−22.3% | Reduced | Holders |
| Q1 2021 | 172,532 | $48.3M | 0.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.